Simke Demeester
Overview
Explore the profile of Simke Demeester including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
112
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Desouter A, Keymeulen B, Demeester S, Van de Velde U, De Pauw P, Van Dalem A, et al.
Diabetes Res Clin Pract
. 2023 Oct;
205:110974.
PMID: 37884063
Aims: In recent-onset type 1 diabetes, clamp-derived C-peptide predicts good response to anti-CD3. Elevated proinsulin and proinsulin/C-peptide ratio (PI/CP) suggest increased metabolic/inflammatory beta cell burden. We reanalyzed trial data to...
2.
Geers J, Luchian M, Motoc A, De Winter J, Roosens B, Bjerke M, et al.
Int J Cardiovasc Imaging
. 2022 Dec;
39(3):585-593.
PMID: 36471103
Purpose: The aim of the present study was to evaluate the role of ejection fraction (EF), left ventricular (LV) global longitudinal strain (LVGLS) and global constructive work (GCW) as prognostic...
3.
Herroelen P, Demeester S, Damiaens S, Evenepoel A, Jochmans K
Int J Lab Hematol
. 2021 Sep;
44(1):96-103.
PMID: 34582122
Introduction: Body fluid cell counting and differentiation provide essential information for diagnosis and monitoring of diverse pathologies. We evaluated the performance of the newly launched Abbott Alinity hq hematology analyzer...
4.
Demeester S, Demuyser T, Fauconnier C, Heestermans R, Orlando C, Depreter B, et al.
Int J Lab Hematol
. 2020 Sep;
42(6):e252-e255.
PMID: 32915507
No abstract available.
5.
Balke E, Demeester S, Lee D, Gillard P, Hilbrands R, Van de Velde U, et al.
Diabetologia
. 2018 Apr;
61(7):1623-1632.
PMID: 29679103
Aims/hypothesis: HLA-A*24 carriership hampers achievement of insulin independence in islet allograft recipients. However, less than half of those who fail to achieve insulin independence carry the allele. We investigated whether...
6.
Balke E, Balti E, Van der Auwera B, Weets I, Costa O, Demeester S, et al.
Diabetes Care
. 2018 Mar;
41(5):1076-1083.
PMID: 29545461
Objective: We investigated the effect of HLA class I risk alleles on disease progression in various phases of subclinical islet autoimmunity in first-degree relatives of patients with type 1 diabetes....
7.
Gorus F, Balti E, Messaaoui A, Demeester S, Van Dalem A, Costa O, et al.
Diabetes Care
. 2017 Jul;
40(8):1065-1072.
PMID: 28701370
Objective: We investigated whether islet autoantibody profile, genotype, and age influenced a 20-year progression to diabetes from first autoantibody positivity (autoAb) in first-degree relatives of patients with type 1 diabetes....
8.
Van Dalem A, Demeester S, Balti E, Keymeulen B, Gillard P, Lapauw B, et al.
PLoS One
. 2017 Jun;
12(6):e0179108.
PMID: 28570714
[This corrects the article DOI: 10.1371/journal.pone.0166702.].
9.
Van Dalem A, Demeester S, Balti E, Keymeulen B, Gillard P, Lapauw B, et al.
PLoS One
. 2016 Dec;
11(12):e0166702.
PMID: 27907006
Background: The hyperglycemic clamp test, the gold standard of beta cell function, predicts impending type 1 diabetes in islet autoantibody-positive individuals, but the latter may benefit from less invasive function...
10.
Demeester S, Balke E, Van der Auwera B, Gillard P, Hilbrands R, Lee D, et al.
Diabetes Care
. 2016 May;
39(6):1060-4.
PMID: 27208324
Objective: We investigated whether changes in islet autoantibody profile and presence of HLA risk markers, reported to predict rapid β-cell loss in pre-type 1 diabetes, associate with poor functional outcome...